The 2nd Annual Innovative Pharma Pricing & Market Access Strategies 2018 covers topics such as:
- Biosimilars and their influence on pricing and reimbursement
- The impact of pricing policies on Pharmaceutical Innovation
- Balancing value & affordability for a new orphan product
- Pricing strategy: Price premiums vs discounts: What’s best?
- Development of alternative payment models
- Improving value proposition with HTA
- Fostering a successful tendering management strategy
- Persuading payers for expensive new treatments with RWE
- Maximizing your market access strategies by knowing regulatory trends
- Ensuring market access success
- The contribution of marketing intelligence to pharmaceutical market access
- Patient-centered approaches that help advance market access goals
The 2nd Annual Innovative Pharma Pricing & Market Access Strategies 2018 brings together senior attendees with responsibilities in:
- Marketing
- Business Development
- Pricing
- Sales
- Medical Director
- Market Access
- Drug Pricing
- Marketing Intelligence
- Health Economics
- Product Launch
- Product Reimbursement
- Pricing Policy
- Real World Evidence
- Health Technology Assessment
- Data Sciences
- Health Informatics
- P&MA
- Value Strategy
- Tendering
